🇺🇸 FDA
Patent

US 9180198

Slow-release cilostazol tablet having an improved elution rate and minimal side effects

granted A61KA61K31/4709A61K47/32

Quick answer

US patent 9180198 (Slow-release cilostazol tablet having an improved elution rate and minimal side effects) held by KOREA UNITED PHARM. INC. expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
KOREA UNITED PHARM. INC.
Grant date
Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/4709, A61K47/32, A61K47/38, A61K9/2027